CLPBY Coloplast A/S
Coloplast A/S (CLPBY) is expected to report earnings on February 2, 2027, before the market open. The consensus earnings estimate is $0.10 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of +2.3% since its last earnings release on November 3, 2026.
Sign in or subscribe to unlock sentiment, short interest, and technical indicators.
Whisperings™
About Coloplast A/S
Coloplast A/S engages in the development and sale of intimate healthcare products and services principally in Denmark, the United States, the United Kingdom, France and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology and Advanced Wound Care segments. Coloplast A/S is based in Humleb?k, Denmark.
Sector
Healthcare
Industry
Medical Instruments/Supply
Charts powered in part by Lightweight Charts™ by TradingView.